AstraZeneca PLC is 1.0x more valuable than Novartis AG by market capitalization ($286.27 B vs $283.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NVS | AZN |
|---|---|---|
| Market cap | $283.13 B | $286.27 B |
| US-listed rank | #47 | #45 |
| SEC filings | 947 | 1,004 |
AstraZeneca PLC is 1.0x more valuable than Novartis AG by market capitalization ($286.27 B vs $283.13 B).
Full pages: Novartis AG and AstraZeneca PLC, or browse the full rankings.